🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and tolerability of vario...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-22
Trial ID
NCT02315703
Treatments Being Tested
UKHVC Spoke 003 is a randomised Phase I, two centre study which will explor...
Status
Completed
Location
Surrey Clinical Research Centre, University of Surrey
Start Date
2013-06
Trial ID
NCT01922284
Treatments Being Tested
CUTHIVAC002 is a randomised Phase I study aimed at exploring the safety and...
Status
Completed
Location
NIHR/Wellcome Trust Imperial Clinical Research Facility, Hammersmith Hospital, Imperial College Healthcare NHS Trust
Start Date
2016-08-11
Trial ID
NCT02589795
The primary purpose of this study is to assess safety, tolerability of the ...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-28
Trial ID
NCT02685020
Treatments Being Tested
Sub-Saharan Africa is the region most affected by the global Human Immunode...
Status
Completed
Location
Perinatal HIV Research Unit
Start Date
2011-12-19
Trial ID
NCT01418235
Treatments Being Tested
An Open-Label Study to Evaluate the Safety and Immunogenicity of 2 Doses of...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05863585
Treatments Being Tested
The primary purpose of this study is to assess safety/tolerability of 2 dif...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-03-05
Trial ID
NCT03307915
Treatments Being Tested
The purpose of this study is to evaluate the safety and immune response to ...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01927835
This study will evaluate the safety of and the body's immune response to ex...
Status
Completed
Location
HVTN Clinical Research Site (HVTN CRS) ,
Start Date
2012-08
Trial ID
NCT01799954
The purpose of this study is to assess the safety and tolerability of 2 dif...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02304185
Treatments Being Tested